Acute Lung Injury(ALI) Clinical Trials
2 recruiting trials for Acute Lung Injury(ALI). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Lung Injury(ALI) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Beijing Tsinghua Chang Gung Hospital (1), University of Kentucky (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is None-placebo (other, 1 trial).
Track Acute Lung Injury(ALI) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Digital Early Warning System for Acute Lung Injury in Liver Surgery
This study focuses on developing an explainable machine learning model based on cardiopulmonary interaction characteristics to achieve early prediction of acute lung injury (ALI)...
Recovery of Physical Function After Critical Illness In Older Adults
The proposed study is a prospective, observational study assessing the recovery of muscle and physical function in patients surviving critical illness (n =150) at hospital...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Lung Injury(ALI), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Lung Injury(ALI), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Lung Injury(ALI), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.